RATIONALE AND APPLICATIONS FOR MACROMOLECULAR GD-BASED CONTRAST AGENTS
RATIONALE AND APPLICATIONS FOR MACROMOLECULAR GD-BASED CONTRAST AGENTS
复制标题
DOI:
10.1002/mrm.1910220225
复制
发表时间:
1991-12-01
影响因子:
3.3
通讯作者:
BRASCH, RC
中科院分区:
文献类型:
--
作者:
BRASCH, RC
Macromolecular contrast media (MMCM) for MRI may be defined as paramagnetic or superparamagnetic compounds of sufficient molecular weight, generally> 20,000 daltons, that demonstrate prolonged intravascular retention. As opposed to relatively smaller molecules, such as Gd-DTPA dimeglumine (cation MW= 547 daltons), which rapidly equilibrate between the blood and the extravascular interstitial space, macromolecular MRI contrast media are designed primarily to enhance the blood pool and sites of abnormal endothelial permeability. Over the past several years our laboratory and others have investigated and compared the properties of several MMCM including albumin-(Gd-DTPA) 30, dextran-(Gd-DTPA) 15, and polylysine-(Gd-DTPA) 50 (I-15). Physicochemical and pharmacokinetic properties of these compounds are briefly compared in Table 1. Additional formulations that have the potential to enhance the blood pool include labeled liposomes, particulates, and erythrocytes.Each of the compounds in Table 1 demonstrates a plasma half-life of at least 60 min in rats and some produce a near-constant enhancement of normal tissues for 60 min or longer. Although a major research goal is to identify a superior MMCM to carry forward into clinical trials, this summary will focus on unique characteristics of MMCM and on potential clinical applications defined by experimental studies in vitro and in animals. Complete characterizations and detailed comparison of contending formulations is beyond the scope of this summary.